Traditional Chinese medicine composition for treating liver-depression and qi-stagnation I-type gastric neuroendocrine tumor

Abstract

The invention belongs to the technical field of medicine and particularly relates to a traditional Chinese medicine composition for treating liver-depression and qi-stagnation I-type gastric neuroendocrine tumor. The traditional Chinese medicine composition consists of the following traditional Chinese medicines in parts by weight: 4-8 parts of all grass of David vetchling, 4-8 parts of fruit of manglietia yuyuanensis law, 4-8 parts of leaf of Japanese pagodatree, 4-8 parts of common anotis herb, 4-8 parts of phyllan lhus mat shilllirae, 4-8 parts of szechwan indigo herb, 4-8 parts of aesculus chinensis bge, 4-8 parts of litsea cubeba, 4-8 parts of root of fortune apios and 4-8 parts of liquorice. The medicines together realize the functions of soothing liver and resolving depression and regulating qi and dispersing mass. The traditional Chinese medicine composition can effectively reduce the serum gastrin, the chromogranin A level and the antibody positive rate of parietal cells of a patient so as to improve the lack conditions of gastric acid and vitamin B12.

Description

technical field [0001] The invention belongs to the technical field of medicines, and in particular relates to a traditional Chinese medicine composition for treating type I gastric neuroendocrine tumors of liver depression and qi stagnation. Background technique [0002] Gastric neuroendocrine tumors include well-differentiated and poorly differentiated. Well-differentiated gastric neuroendocrine tumors are divided into three types, namely type I gastric neuroendocrine tumors, which are related to type A CAG, have a high recurrence rate, and have a good prognosis. Type II gastric neuroendocrine neoplasia, associated with Zoe Ellison syndrome / MEN-1 (multiple neuroendocrine neoplasia type 1). Type Ⅲ gastric neuroendocrine tumor, no special disease in the past, sporadic. [0003] The occurrence of type I G-NEN is related to the excessive proliferation of E cells, and its pathogenesis is as follows: when food enters the stomach, it stimulates G cells in the gastric antrum to s...

AI Technical Summary

Problems solved by technology

[0005] At present, Western medicine is not completely clear about the pathogenesis of type I gastric neuroendocrine tumors, and there is no effective treatment in terms of treatment.

[0006] Liver stagnation and qi stagnation are common types of type I gastric neuroendocrine tumors, and there is no specific drug for this type of gastric neuroendocrine tumors at present.